Long-Term Liabilities. 7
Contingent Liabilities. 8
Issued Capital Amount 8
Liquidity of the Company. 8
Current Ratio. 9
Quick Ratio. 9
Accounts Receivable Turnover Ratio. 9
Inventory Turnover Ratio. 10
References. 10
Executive Summary
This report will be about the company analysis report for Cordlife Group Limited’s annual
report 2012 (Cordlife Annual Report 2012, Page 1). We will be going through the
information of the company such as what the types of business undertake and the internal
factors like the auditors of the company. The summary of the consolidated report will be
mention on the company’s financial statement, how is the company doing in their financial
strength.
Introduction
According to Cordlife, 2013, Cordlife Group Limited is a leading service provider of stem
cell banking from cord blood and the umbilical cord, who currently owned and operates
two stem cell banks with full processing and cryopreservation storage facilities in
Singapore and Hong Kong and having affiliates who are operating in India, Indonesia and
the Philippines.
Corporate Information
Cordlife was started in Singapore in May 2001, having a unique space in the healthcare
industry and being one of the first private cord blood banks to be established in Asia.
Cordlife is the first private cord blood bank to released cord blood units for the treatment
of cerebral palsy and first in Singapore and Hong Kong cord blood units for transplants
and other therapeutic used (Cordlife Annual Report 2012, Page 9).